Historical catalog analysis: CISA added this entry on July 22, 2025. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.
What the vulnerability is
CVE-2025-2775 is an improper restriction of XML External Entity Reference (CWE-611) vulnerability affecting SysAid On-Prem. The flaw exists within the product’s checkin processing functionality. If exploited, this vulnerability could allow an attacker to achieve administrator account takeover and utilize file read primitives to access sensitive data on the system.
Exposure and applicability
This vulnerability is applicable to healthcare providers, practices, and business associates utilizing SysAid On-Prem for IT service management (ITSM). Because ITSM tools often hold centralized visibility into a healthcare organization’s hardware, software assets, and administrative credentials, an administrator account takeover could provide a pivot point into broader clinical networks. The ability to read arbitrary files may further expose configuration data or sensitive system information, potentially impacting the confidentiality of ePHI if such data is stored or accessible via the affected server.
Remediation priorities
Our analysis suggests that healthcare security leaders prioritize the following actions based on the risk to operational resilience:
- Inventory and Version Verification: IT administrators should immediately identify all instances of SysAid On-Prem within the environment to determine if they are running versions susceptible to this flaw.
- Vendor Mitigation Application: Following vendor instructions to apply available patches or mitigations is the primary method for reducing exposure. This should be coordinated with clinical engineering to ensure that updates do not disrupt critical support workflows.
- Access Review: Security teams should review administrative account permissions within SysAid to ensure the principle of least privilege is applied, which could limit the impact if an account takeover occurs.
- Decommissioning Evaluation: In scenarios where mitigations are unavailable or cannot be safely applied, organizations should evaluate whether to discontinue use of the product to eliminate the risk vector.
How to validate remediation
To verify that exposure has been reduced, administrators can perform a version check against the vendor’s patched release documentation. While a version check does not guarantee total security, it provides evidence that the known vulnerability has been addressed. Additionally, security teams may review system logs for unauthorized administrative changes or unusual file access patterns associated with the checkin processing functionality to ensure no prior compromise occurred.
Limits and open questions
It remains unknown whether this vulnerability has been utilized in active ransomware campaigns. Furthermore, while patching addresses the specific XML external entity flaw, it does not eliminate other potential account takeover vectors. Organizations should note that CISA’s federal agency deadline of August 12, 2025, is a requirement for covered federal agencies and not a legal mandate for private healthcare entities, though it serves as a useful benchmark for risk management timelines.
Source and editorial note
CVE-2025-2775: SysAid On-Prem Improper Restriction of XML External Entity Reference Vulnerability · Source date: July 22, 2025 · Retrieved August 31, 2026.
Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.
Archive date: July 25, 2025. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: October 05, 2026 at 01:00 UTC.
Request a healthcare security assessment
Turn healthcare security intelligence into action.
Discuss your environment, priorities, and the evidence needed to validate safeguards.
Request a healthcare assessment ↗